KENILWORTH (NJ) (dpa-AFX) – Merck & Co., Inc. (MRK), a pharmaceutical company, on Thursday reported a net loss for the first quarter of 2026 due to acquisition charges. However, the drugmaker reco…
Merck Slips To Q1 Loss On Acquisition Charges, But Sales Improve, Revises Annual Outlook; Stock Up
Source: Finanznachrichten.de
Read Full Story →
